Insulet Corporation
PODD Real Time Price USD$PODD is featured in our Tina Smith strategy.
See All StrategiesRecent trades of PODD by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by PODD's directors and management
Government lobbying spending instances
-
$50,000 Oct 18, 2024 Issue: Health Issues
-
$160,000 Jul 19, 2024 Issue: Health Issues
-
$70,000 Apr 22, 2024 Issue: Health Issues
-
$60,000 Jan 19, 2024 Issue: Health Issues
-
$100,000 Oct 20, 2023 Issue: Health Issues
-
$60,000 Jul 18, 2023 Issue: Health Issues
-
$50,000 Jan 19, 2023 Issue: Health Issues
-
$50,000 Oct 14, 2022 Issue: Health Issues
-
$50,000 Jul 18, 2022 Issue: Health Issues
-
$40,000 Apr 18, 2022 Issue: Health Issues
-
$10,000 Jan 20, 2022 Issue: Health Issues
-
$10,000 Apr 19, 2018 Issue: Health Issues Medicare/Medicaid
-
$50,000 Apr 09, 2018 Issue: Health Issues
-
$40,000 Jan 19, 2018 Issue: Health Issues Medicare/Medicaid
-
$140,000 Jan 18, 2018 Issue: Medicare/Medicaid
-
$15,000 Jan 16, 2018 Issue: Health Issues
-
$60,000 Oct 18, 2017 Issue: Health Issues Medicare/Medicaid
-
$140,000 Oct 17, 2017 Issue: Medicare/Medicaid
-
$120,000 Jul 21, 2017 Issue: Medicare/Medicaid
-
$40,000 Jul 19, 2017 Issue: Health Issues Medicare/Medicaid
-
$90,000 Apr 24, 2017 Issue: Medicare/Medicaid
-
$20,000 Apr 20, 2017 Issue: Health Issues Medicare/Medicaid
-
$90,000 Jan 19, 2017 Issue: Medicare/Medicaid
-
$60,000 Oct 14, 2016 Issue: Medicare/Medicaid
-
$40,000 Jul 19, 2016 Issue: Medicare/Medicaid
-
$40,000 Apr 20, 2016 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2016 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2015 Issue: Medicare/Medicaid
-
$35,000 Jul 29, 2015 Issue: Medicare/Medicaid
-
$30,000 Jul 20, 2015 Issue: Medicare/Medicaid
-
$35,000 Jan 20, 2015 Issue: Medicare/Medicaid
-
$20,000 Oct 16, 2014 Issue: Medicare/Medicaid
-
$30,000 Jul 17, 2014 Issue: Medicare/Medicaid
-
$20,000 Apr 11, 2014 Issue: Medicare/Medicaid
-
$20,000 Jan 16, 2014 Issue: Medicare/Medicaid
-
$30,000 Oct 18, 2013 Issue: Medicare/Medicaid
-
$40,000 Jul 19, 2013 Issue: Medicare/Medicaid
-
$10,000 Jan 22, 2013 Issue: Medicare/Medicaid
-
$40,000 Oct 22, 2012 Issue: Medicare/Medicaid
-
$30,000 Jan 20, 2012 Issue: Health Issues
-
$30,000 Oct 20, 2011 Issue: Health Issues
-
$30,000 Jul 20, 2011 Issue: Health Issues
-
$30,000 Apr 25, 2011 Issue: Health Issues
-
$30,000 Jan 20, 2011 Issue: Health Issues
-
$30,000 Oct 21, 2010 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Drug delivery device with integrated optical-based glucose monitor Oct. 29, 2024
-
Patent Title: Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system Oct. 22, 2024
-
Patent Title: Open-loop insulin delivery basal parameters based on insulin delivery records Oct. 22, 2024
-
Patent Title: Secure wireless communications between a glucose monitor and other devices Oct. 15, 2024
-
Patent Title: Occlusion resolution in medication delivery devices, systems, and methods Oct. 01, 2024
-
Patent Title: Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation Sep. 24, 2024
-
Patent Title: Wearable micro-dosing drug delivery device Sep. 24, 2024
-
Patent Title: Low-friction rolling plunger for a wearable drug delivery device Sep. 17, 2024
-
Patent Title: Safety constraints for a control algorithm based drug delivery system Sep. 17, 2024
-
Patent Title: Alarms and alerts for medication delivery devices and systems Sep. 03, 2024
-
Patent Title: Infusion pump system and method Aug. 20, 2024
-
Patent Title: Infusion pump assembly and method Aug. 06, 2024
-
Patent Title: System and method for adjusting insulin delivery Jul. 23, 2024
-
Patent Title: Prediction of meal and/or exercise events based on persistent residuals Jul. 16, 2024
-
Patent Title: Drug delivery insertion apparatuses and system May. 28, 2024
-
Patent Title: Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk May. 21, 2024
-
Patent Title: Insulin delivery methods, systems and devices Apr. 30, 2024
-
Patent Title: Automated drug delivery device Apr. 23, 2024
-
Patent Title: Techniques and devices providing adaptivity and personalization in diabetes treatment Apr. 16, 2024
-
Patent Title: Infusion pump system and methods Apr. 16, 2024
-
Patent Title: Onboarding and total daily insulin adaptivity Mar. 19, 2024
-
Patent Title: User interface for diabetes management system Mar. 12, 2024
-
Patent Title: Infusion pump system and methods Mar. 05, 2024
-
Patent Title: Initial total daily insulin setting for user onboarding Feb. 27, 2024
-
Patent Title: Adaptable asymmetric medicament cost component in a control system for medicament delivery Feb. 20, 2024
-
Patent Title: Safety constraints for a control algorithm based drug delivery system Jan. 30, 2024
-
Patent Title: Infusion pump systems and methods Jan. 09, 2024
-
Patent Title: Display screen with a graphical user interface Jan. 09, 2024
-
Patent Title: Network topology for insulin pump systems Jan. 02, 2024
-
Patent Title: Adjusting insulin delivery rates Jan. 02, 2024
-
Patent Title: Display screen with a graphical user interface Dec. 12, 2023
-
Patent Title: Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns Dec. 05, 2023
-
Patent Title: Needle mechanism module for drug delivery device Nov. 21, 2023
-
Patent Title: Blood glucose rate of change modulation of meal and correction insulin bolus quantity Oct. 31, 2023
-
Patent Title: Network topology for insulin pump systems Oct. 24, 2023
-
Patent Title: Drug delivery devices, systems, and methods with force transfer elements Oct. 17, 2023
-
Patent Title: Micro piston pump Sep. 05, 2023
-
Patent Title: Wearable automated medication delivery system Sep. 05, 2023
-
Patent Title: Techniques enabling adaptation of parameters in aid systems by user input Aug. 29, 2023
-
Patent Title: Low force valves for drug delivery pumps Aug. 15, 2023
-
Patent Title: Fluid delivery device with sensor Aug. 15, 2023
-
Patent Title: Techniques to reduce risk of occlusions in drug delivery systems Jun. 27, 2023
-
Patent Title: Fluid delivery device, transcutaneous access tool and insertion mechanism for use therewith Jun. 27, 2023
-
Patent Title: Drug cartridge with drive system Jun. 13, 2023
-
Patent Title: Semi-rigid and flexible elements for wearable drug delivery device reservoir May. 30, 2023
-
Patent Title: Cartridge hold-up volume reduction Apr. 25, 2023
-
Patent Title: Activity mode for artificial pancreas system Apr. 18, 2023
-
Patent Title: Initial total daily insulin setting for user onboarding Mar. 21, 2023
-
Patent Title: Fluid delivery and infusion devices, and methods of use thereof Mar. 07, 2023
-
Patent Title: Display screen with graphical user interface Feb. 07, 2023
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of PODD in WallStreetBets Daily Discussion
Recent insights relating to PODD
Recent picks made for PODD stock on CNBC
ETFs with the largest estimated holdings in PODD
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PODD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.